ID: ALA4645229

Max Phase: Preclinical

Molecular Formula: C20H22N4

Molecular Weight: 318.42

Molecule Type: Unknown

Representations

Canonical SMILES:  Nc1ccccc1-c1cc(NC2CCCNC2)c2ccncc2c1

Standard InChI:  InChI=1S/C20H22N4/c21-19-6-2-1-5-17(19)14-10-15-12-23-9-7-18(15)20(11-14)24-16-4-3-8-22-13-16/h1-2,5-7,9-12,16,22,24H,3-4,8,13,21H2

Standard InChI Key:  FKJNUFATJIQZEN-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 318.42

Molecular Weight (Monoisotopic): 318.1844

AlogP: 3.65

#Rotatable Bonds: 3

Polar Surface Area: 62.97

Molecular Species: BASE

HBA: 4

HBD: 3

#RO5 Violations: 0

HBA (Lipinski): 4

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 9.55

CX LogP: 2.14

CX LogD: 0.01

Aromatic Rings: 3

Heavy Atoms: 24

QED Weighted: 0.65

Np Likeness Score: -0.44

References

1. Atobe M, Serizawa T, Yamakawa N, Takaba K, Nagano Y, Yamaura T, Tanaka E, Tazumi A, Bito S, Ishiguro M, Kawanishi M..  (2020)  Discovery of 4,6- and 5,7-Disubstituted Isoquinoline Derivatives as a Novel Class of Protein Kinase C ζ Inhibitors with Fragment-Merging Strategy.,  63  (13): [PMID:32551607] [10.1021/acs.jmedchem.0c00449]

Source

Source(1):

• Scientific Literature